Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04867837 |
| Consolidated Lead Sponsor | Octapharma |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 100 participants (ACTUAL) |
| Registered Start Date | 2021-09-01 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| UCLA Health and Jonsson Comprehensive Cancer Center | Los Angeles, CA | Open Hospital Dossier -> |
| Beth Israel Deaconess Medical Center | Boston, MA | Open Hospital Dossier -> |
| Hennepin County Medical Center | Minneapolis, MN | Open Hospital Dossier -> |
| University of Mississippi Medical Center | Jackson, MS | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.